$42.19
0.96% today
Nasdaq, Apr 01, 06:49 pm CET
ISIN
US40131M1099
Symbol
GH

Guardant Health, Inc. Stock price

$42.60
+0.05 0.12% 1M
+19.66 85.70% 6M
+12.05 39.44% YTD
+22.35 110.37% 1Y
-23.64 35.69% 3Y
-27.00 38.79% 5Y
+10.40 32.30% 10Y
Nasdaq, Closing price Mon, Mar 31 2025
-0.54 1.25%
ISIN
US40131M1099
Symbol
GH
Sector

Key metrics

Market capitalization $5.26b
Enterprise Value $5.75b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 7.79
P/S ratio (TTM) P/S ratio 7.11
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 31.04%
Revenue (TTM) Revenue $739.02m
EBIT (operating result TTM) EBIT $-443.59m
Free Cash Flow (TTM) Free Cash Flow $-274.94m
Cash position $839.98m
EPS (TTM) EPS $-3.56
P/E forward negative
P/S forward 6.14
EV/Sales forward 6.72
Short interest 7.05%
Show more

Is Guardant Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Guardant Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

25 Analysts have issued a Guardant Health, Inc. forecast:

22x Buy
88%
2x Hold
8%
1x Sell
4%

Analyst Opinions

25 Analysts have issued a Guardant Health, Inc. forecast:

Buy
88%
Hold
8%
Sell
4%

Financial data from Guardant Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
739 739
31% 31%
100%
- Direct Costs 290 290
27% 27%
39%
449 449
34% 34%
61%
- Selling and Administrative Expenses 503 503
2% 2%
68%
- Research and Development Expense 348 348
5% 5%
47%
-401 -401
23% 23%
-54%
- Depreciation and Amortization 42 42
1% 1%
6%
EBIT (Operating Income) EBIT -444 -444
21% 21%
-60%
Net Profit -436 -436
9% 9%
-59%

In millions USD.

Don't miss a Thing! We will send you all news about Guardant Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Guardant Health, Inc. Stock News

Neutral
MarketBeat
3 days ago
The American stock markets have had a rough month as investors remain jittery over international tariff fears. While this market downturn has affected most sectors of the economy, healthcare stocks are doing exceptionally well, outperforming the general market as the most successful sector of 2025 so far.
Neutral
Business Wire
7 days ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer (CRC) screening is now covered by a key healthcare insurance program for U.S. veterans. The screening test is covered for patients receiving community care authorized by the U.S. Department of Veterans Affairs (VA) as an in-ne...
Positive
Seeking Alpha
19 days ago
Guardant Health basically leads in liquid biopsy oncology diagnostics using genomic and digital technologies for early cancer detection. One of its main offerings is Guardant360, which is currently generating record revenues and growth for GH. Similarly, GH has an expanding pipeline, which includes its Reveal and Shield tests, that could significantly boost its future market potential.
More Guardant Health, Inc. News

Company Profile

Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA.

Head office United States
CEO Helmy Eltoukhy
Employees 2,021
Founded 2012
Website www.guardanthealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today